Parasitic adaptive mechanisms in infection by Leishmania

被引:159
作者
Cunningham, AC [1 ]
机构
[1] Univ Tennessee, Dept Pathol, Memphis, TN 38163 USA
关键词
Leishmania; leishmaniasis; macrophage; sand fly; parasite; adaptive mechanisms;
D O I
10.1006/exmp.2002.2418
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Leishmania are a resilient group of intracellular parasites that infect macrophages. The resultant complex of diseases, or leishmaniases, caused by the parasites affect over twelve million people worldwide. Leishmania have developed unique adaptive mechanisms to ensure their survival in the harsh environments faced throughout their life cycle. These parasites must not only contend with the hostile digestive conditions found within the sand fly vector, but they must also avoid destruction by the host immune system while in the bloodstream, before entering the macrophage. To do so, Leishmania express unique lipophosphoglycan (LPG) molecules and the metalloprotease gp63, among other proteins, on their cell surface. To enter the macrophage, Leishmania utilizes a variety of cellular receptors to mediate endocytosis. Once inside the macrophage, Leishmania is protected from phagolysosome degradation by a variety of adaptations to inhibit cellular defense mechanisms. These include the inhibition of phagosome-endosome fusion, hydrolytic enzymes, cell signaling pathways, nitric oxide production, and cytokine production. While other parasites can also infect macrophages, Leishmania is distinctive in that it not only relies on its own defenses to survive and reproduce within the macrophage phagolysosome, but Leishmania also manipulates the host immune response in order to protect itself and to gain entry into the cell. These unique adaptive mechanisms help promote Leishmania survival. (C) 2002 Elsevier Science (USA).
引用
收藏
页码:132 / 141
页数:10
相关论文
共 109 条
[11]   MODULATION OF MACROPHAGE FUNCTION BY TRANSFORMING GROWTH-FACTOR-BETA, INTERLEUKIN-4, AND INTERLEUKIN-10 [J].
BOGDAN, C ;
NATHAN, C .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1993, 685 :713-739
[12]  
Bozza M, 1998, EUR J IMMUNOL, V28, P3120, DOI 10.1002/(SICI)1521-4141(199810)28:10<3120::AID-IMMU3120>3.0.CO
[13]  
2-3
[14]   Exploitation of the complement system by Leishmania promastigotes [J].
Brittingham, A ;
Mosser, DM .
PARASITOLOGY TODAY, 1996, 12 (11) :444-447
[15]  
BRITTINGHAM A, 1995, J IMMUNOL, V155, P3102
[16]   INTERLEUKIN-10 DIFFERENTIALLY REGULATES B7-1 (CD80) AND B7-2 (CD86) EXPRESSION ON HUMAN PERIPHERAL-BLOOD DENDRITIC CELLS [J].
BUELENS, C ;
WILLEMS, F ;
DELVAUX, A ;
PIERARD, G ;
DELVILLE, JP ;
VELU, T ;
GOLDMAN, M .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (09) :2668-2672
[17]   Deficiency in beta 1,3-galactosyltransferase of a Leishmania major lipophosphoglycan mutant adversely influences the Leishmania sand fly interaction [J].
Butcher, BA ;
Turco, SJ ;
Hilty, BA ;
Pimenta, PF ;
Panunzio, M ;
Sacks, DL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (34) :20573-20579
[18]   Leishmania promastigotes selectively inhibit interleukin 12 induction in bone marrow-derived macrophages from susceptible and resistant mice [J].
Carrera, L ;
Gazzinelli, RT ;
Badolato, R ;
Hieny, S ;
Muller, W ;
Kuhn, R ;
Sacks, DL .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (02) :515-526
[19]   MICROBIAL GLYCOLIPIDS - POSSIBLE VIRULENCE FACTORS THAT SCAVENGE OXYGEN RADICALS [J].
CHAN, J ;
FUJIWARA, T ;
BRENNAN, P ;
MCNEIL, M ;
TURCO, SJ ;
SIBILLE, JC ;
SNAPPER, M ;
AISEN, P ;
BLOOM, BR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (07) :2453-2457